Literature DB >> 10882298

Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia.

J A Schroeder1, D C Lee.   

Abstract

Transforming growth factor-alpha (TGFalpha)4 and/or the EGF receptor (EGFR) are frequently overexpressed by human and rodent breast tumors, as well as tumor-derived cell lines. Additionally, various observations suggest a role for TGFalpha and the EGFR signaling system in normal mouse mammary gland development. Recently, several laboratories have established TGFalpha transgenic mice with which to study the role of this growth factor in normal and neoplastic mammary biology. Examination of these mice revealed that overexpression of TGFalpha has profound consequences for this tissue. Most strikingly, transgenic mice expressing TGFalpha under the control of tissue-specific and nonspecific promoters stochastically developed focal mammary tumors with an incidence and latency that was markedly affected by pregnancy. Most TGFalpha-induced tumors were well-differentiated adenomas/adenocarcinomas, although some were undifferentiated and locally invasive. Distant metastases were only occasionally observed. Administration of the genotoxic carcinogen, 7,12-dimethylbenzanthracene (DMBA), dramatically accelerated mammary tumorigenesis induced by the TGFalpha transgene, raising the possibility that TGFalpha acts as a promoter in this tissue. Mice harboring dual transgenes encoding TGFalpha and either wild-type ERBB2 or c-myc displayed markedly accelerated tumorigenesis compared to mice carrying any of the single transgenes alone, indicative of potent cooperativity. Moreover, tumorigenesis in the bitransgenic mice was less dependent on pregnancy, and tumors were generally more malignant in appearance. Finally, TGFalpha also affected mammary gland dynamics. TGFalpha transgenic mice consistently displayed precocious alveolar development, were variably impaired with respect to lactation, and showed markedly reduced postlactional involution. As a result, the glands of multiparous females accumulated hyperplastic lesions that generally resembled milk-producing alveoli. Limited data support the hypothesis that these lesions were precursors to TGFalpha-induced tumors. In summary, these various findings underscore the potential importance of TGFalpha for cellular differentiation and transformation in the mammary gland. They also establish TGFalpha transgenic mice as a powerful model with which to study the role of EGFR signaling molecules in this dynamic tissue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10882298     DOI: 10.1023/a:1026347629876

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  62 in total

Review 1.  Transforming growth factor alpha: expression, regulation, and biological activities.

Authors:  D C Lee; S E Fenton; E A Berkowitz; M A Hissong
Journal:  Pharmacol Rev       Date:  1995-03       Impact factor: 25.468

2.  Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.

Authors:  L W Lee; V W Raymond; M S Tsao; D C Lee; H S Earp; J W Grisham
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

3.  Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Authors:  Y Matsui; S A Halter; J T Holt; B L Hogan; R J Coffey
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

4.  Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.

Authors:  E P Sandgren; J A Schroeder; T H Qui; R D Palmiter; R L Brinster; D C Lee
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

5.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.

Authors:  E Schuuring; E Verhoeven; W J Mooi; R J Michalides
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

6.  Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.

Authors:  G H Smith; R Sharp; E C Kordon; C Jhappan; G Merlino
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

7.  Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia.

Authors:  S Tanaka; K Imanishi; M Yoshihara; K Haruma; K Sumii; G Kajiyama; S Akamatsu
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

8.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

9.  Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.

Authors:  R J Coffey; K S Meise; Y Matsui; B L Hogan; P J Dempsey; S A Halter
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Expression of transforming growth factor-alpha in primary human colon and lung carcinomas.

Authors:  C Liu; A Woo; M S Tsao
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more
  8 in total

Review 1.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling.

Authors:  Joyce A Schroeder; Leslie F Jackson; David C Lee; Todd D Camenisch
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

Review 2.  The ErbB receptors as targets for breast cancer therapy.

Authors:  J Albanell; J Baselga
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

Review 3.  Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network.

Authors:  K L Troyer; D C Lee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 4.  Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast.

Authors:  S A Bartow
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 5.  ErbB signaling in cardiac development and disease.

Authors:  Pablo Sanchez-Soria; Todd D Camenisch
Journal:  Semin Cell Dev Biol       Date:  2010-10-07       Impact factor: 7.727

6.  Matrix hyaluronan alters epidermal growth factor receptor-dependent cell morphology.

Authors:  Jeanne M V Louderbough; Jose I Lopez; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2010-01-29       Impact factor: 3.405

7.  Intracellular MUC1 peptides inhibit cancer progression.

Authors:  Benjamin G Bitler; Ina Menzl; Carmen L Huerta; Barbara Sands; Wendy Knowlton; Andrew Chang; Joyce A Schroeder
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

8.  Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche.

Authors:  Pegah Ghiabi; Jie Jiang; Jennifer Pasquier; Mahtab Maleki; Nadine Abu-Kaoud; Najeeb Halabi; Bella S Guerrouahen; Shahin Rafii; Arash Rafii
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.